• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAN
Click for more information
0.00% 4.6¢

CANN GROUP LIMITED - Announcements

Market Cap $17.80M  ! watchlist Created with Sketch. Add to my watchlist

Cann Group Limited is an Australia-based company that is focused on developing,... Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation, and good manufacturing practices (GMP) manufacturing facilities are in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CAN Investor Presentation19/09/24
CAN Investor PresentationPRICE SENSITIVE21/03/19
CAN Revised expansion plans and offtake agreement executedPRICE SENSITIVE19/03/19
CAN Half Yearly Report and Accounts18/02/19
CAN Appendix 4DPRICE SENSITIVE18/02/19
CAN Appendix 4C - quarterlyPRICE SENSITIVE30/01/19
CAN Change of Director's Interest Notice24/12/18
CAN Notice under s708(5)(e) amended24/12/18
CAN Notice under s708(5)(e)24/12/18
CAN Appendix 3B24/12/18
CAN Notice under s708(5)(e)21/12/18
CAN Appendix 3B21/12/18
CAN Change of Director's Interest Notice19/12/18
CAN Appendix 4G and Corporate Governance Statement15/11/18
CAN Results of Meeting14/11/18
CAN Chairman & CEO Addresses to ShareholdersPRICE SENSITIVE14/11/18
CAN Cann Market Update PresentationPRICE SENSITIVE30/10/18
CAN Appendix 4C - quarterlyPRICE SENSITIVE30/10/18
CAN Cann secures Victorian Govt tender to supply cannabis resinPRICE SENSITIVE29/10/18
CAN Cann signs R&D Agreement with CSIROPRICE SENSITIVE25/10/18
CAN Notice of Annual General Meeting/Proxy Form12/10/18
CAN Notice given under s708A(5)(e) of Corporations Act13/09/18
CAN Appendix 3B07/09/18
CAN Annual Report PresentationPRICE SENSITIVE23/08/18
CAN Appendix 4G23/08/18
CAN Annual Report to shareholders and Appendix 4EPRICE SENSITIVE23/08/18
CAN Annual Report Conference Call21/08/18
CAN First Aust patients prescribed with Aurora medical cannabisPRICE SENSITIVE15/08/18
CAN IDT: and Cann Group Medicinal Cannabis PartnershipPRICE SENSITIVE07/08/18
CAN Cann signs Research MOU with Agriculture Victoria06/08/18
CAN Cann welcomes first Research Hub for Medicinal AgriculturePRICE SENSITIVE02/08/18
CAN Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
CAN Cann Group corporate office relocation26/07/18 download Created with Sketch. 181.79KB
CAN Site secured for Aust largest medicinal cannabis operationPRICE SENSITIVE27/06/18 download Created with Sketch. 151.04KB
CAN R&D Expansion at La Trobe UniversityPRICE SENSITIVE06/06/18 download Created with Sketch. 148.86KB
CAN Response to ASX Aware QueryPRICE SENSITIVE03/05/18
CAN Takeover speculation in the mediaPRICE SENSITIVE30/04/18
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/04/18
CAN Change of Director's Interest Notice23/04/18
CAN Leading Global Consultancy appointed for Phase 3 facilityPRICE SENSITIVE19/04/18
CAN Change of Director's Interest Notice revised13/04/18
CAN Change of Director's Interest Notice13/04/18
CAN Investor Presentation10/04/18
CAN Ceasing to be a substantial holder03/04/18
CAN S&P DJ Indices Announces March Quarterly RebalancePRICE SENSITIVE09/03/18
CAN Receipt of Import Permits for Genetics and Cannabis OilPRICE SENSITIVE06/03/18
CAN Director Appointment and Appendix 3X01/03/18
CAN Cann executes MOU with Under The Tree BiopharmaceuticalsPRICE SENSITIVE23/02/18
CAN Granting of New Research and Medicinal Cannabis LicencesPRICE SENSITIVE19/02/18
CAN Becoming a substantial holder - AMENDED07/02/18
CAN Amended Becoming a substantial holder notice07/02/18
CAN Becoming a substantial holder07/02/18
CAN Half Yearly Report and Accounts06/02/18
CAN Appendix 4D to Half Yearly Report and AccountsPRICE SENSITIVE06/02/18
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/01/18
CAN Change in substantial holding25/01/18
CAN Change of Director's Interest Notices25/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act24/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act23/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act22/01/18
CAN Appendix 3B19/01/18
CAN Appendix 3B19/01/18
CAN Share Purchase Plan closes heavily oversubscribed19/01/18
CAN Change of Director's Interest Notice17/01/18
CAN Results of Meeting17/01/18
CAN Federal Government Announcement on Medicinal Cannabis ExportPRICE SENSITIVE04/01/18
CAN Ceasing to be a substantial holder22/12/17
CAN Ceasing to be a substantial holder21/12/17
CAN Change in substantial holding21/12/17
CAN New Northern Cultivation and R&D Facility Commissioned20/12/17
CAN Notice of General Meeting/Proxy Form14/12/17
CAN Share Purchase Plan13/12/17
CAN Notice given under section 708A(5)(e) of Corporations Act12/12/17
CAN Appendix 3B12/12/17
CAN Appendix 3B11/12/17
CAN Cann Group Successfully Completes PlacementPRICE SENSITIVE04/12/17
CAN Investor Presentation30/11/17
CAN Fully underwritten $60 million capital raisePRICE SENSITIVE30/11/17
CAN Trading HaltPRICE SENSITIVE29/11/17
CAN Results of Meeting22/11/17
CAN Chairman's & CEO's Address to Shareholders22/11/17
CAN Relocation of Corporate Headquarters to La Trobe University02/11/17
CAN Change of Corporate and Registered Offices02/11/17
CAN Cann Group Granted Cannabis Import / Export LicencePRICE SENSITIVE27/10/17
CAN Licence Variations GrantedPRICE SENSITIVE25/10/17
CAN Notice of Annual General Meeting/Proxy Form18/10/17
CAN Quarterly Activities Report and Appendix 4CPRICE SENSITIVE16/10/17
CAN Cann Investor Presentation September 201701/09/17
CAN Cann Group Joins Medicinal Cannabis Information PortalPRICE SENSITIVE01/09/17
CAN Appendix 4G29/08/17
CAN Appendix 4E and 2017 Annual ReportPRICE SENSITIVE29/08/17
CAN Cann Group Completes First Harvest ProductionPRICE SENSITIVE28/08/17
CAN Cann Group - CannaKorp Agreement AnnouncementPRICE SENSITIVE25/08/17
CAN Price Query ResponsePRICE SENSITIVE18/08/17
CAN Quarterly Activities Report and Quarterly Appendix 4CPRICE SENSITIVE28/07/17
CAN Aurora and Cann Group Execute Technical Services AgreementPRICE SENSITIVE19/07/17
CAN Investor Presentation06/06/17
CAN Cann secures permits to start cultivationPRICE SENSITIVE30/05/17
CAN Becoming a substantial holder09/05/17
CAN Becoming a substantial holder05/05/17
CAN Investor Presentation
19/09/24
CAN Investor Presentation
21/03/19PRICE SENSITIVE
CAN Revised expansion plans and offtake agreement executed
19/03/19PRICE SENSITIVE
CAN Half Yearly Report and Accounts
18/02/19
CAN Appendix 4D
18/02/19PRICE SENSITIVE
CAN Appendix 4C - quarterly
30/01/19PRICE SENSITIVE
CAN Change of Director's Interest Notice
24/12/18
CAN Notice under s708(5)(e) amended
24/12/18
CAN Notice under s708(5)(e)
24/12/18
CAN Appendix 3B
24/12/18
CAN Notice under s708(5)(e)
21/12/18
CAN Appendix 3B
21/12/18
CAN Change of Director's Interest Notice
19/12/18
CAN Appendix 4G and Corporate Governance Statement
15/11/18
CAN Results of Meeting
14/11/18
CAN Chairman & CEO Addresses to Shareholders
14/11/18PRICE SENSITIVE
CAN Cann Market Update Presentation
30/10/18PRICE SENSITIVE
CAN Appendix 4C - quarterly
30/10/18PRICE SENSITIVE
CAN Cann secures Victorian Govt tender to supply cannabis resin
29/10/18PRICE SENSITIVE
CAN Cann signs R&D Agreement with CSIRO
25/10/18PRICE SENSITIVE
CAN Notice of Annual General Meeting/Proxy Form
12/10/18
CAN Notice given under s708A(5)(e) of Corporations Act
13/09/18
CAN Appendix 3B
07/09/18
CAN Annual Report Presentation
23/08/18PRICE SENSITIVE
CAN Appendix 4G
23/08/18
CAN Annual Report to shareholders and Appendix 4E
23/08/18PRICE SENSITIVE
CAN Annual Report Conference Call
21/08/18
CAN First Aust patients prescribed with Aurora medical cannabis
15/08/18PRICE SENSITIVE
CAN IDT: and Cann Group Medicinal Cannabis Partnership
07/08/18PRICE SENSITIVE
CAN Cann signs Research MOU with Agriculture Victoria
06/08/18
CAN Cann welcomes first Research Hub for Medicinal Agriculture
02/08/18PRICE SENSITIVE
CAN Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
CAN Cann Group corporate office relocation
26/07/18 download Created with Sketch. 181.79KB
CAN Site secured for Aust largest medicinal cannabis operation
27/06/18PRICE SENSITIVE download Created with Sketch. 151.04KB
CAN R&D Expansion at La Trobe University
06/06/18PRICE SENSITIVE download Created with Sketch. 148.86KB
CAN Response to ASX Aware Query
03/05/18PRICE SENSITIVE
CAN Takeover speculation in the media
30/04/18PRICE SENSITIVE
CAN Quarterly Activities Report and Appendix 4C
27/04/18PRICE SENSITIVE
CAN Change of Director's Interest Notice
23/04/18
CAN Leading Global Consultancy appointed for Phase 3 facility
19/04/18PRICE SENSITIVE
CAN Change of Director's Interest Notice revised
13/04/18
CAN Change of Director's Interest Notice
13/04/18
CAN Investor Presentation
10/04/18
CAN Ceasing to be a substantial holder
03/04/18
CAN S&P DJ Indices Announces March Quarterly Rebalance
09/03/18PRICE SENSITIVE
CAN Receipt of Import Permits for Genetics and Cannabis Oil
06/03/18PRICE SENSITIVE
CAN Director Appointment and Appendix 3X
01/03/18
CAN Cann executes MOU with Under The Tree Biopharmaceuticals
23/02/18PRICE SENSITIVE
CAN Granting of New Research and Medicinal Cannabis Licences
19/02/18PRICE SENSITIVE
CAN Becoming a substantial holder - AMENDED
07/02/18
CAN Amended Becoming a substantial holder notice
07/02/18
CAN Becoming a substantial holder
07/02/18
CAN Half Yearly Report and Accounts
06/02/18
CAN Appendix 4D to Half Yearly Report and Accounts
06/02/18PRICE SENSITIVE
CAN Quarterly Activities Report and Appendix 4C
31/01/18PRICE SENSITIVE
CAN Change in substantial holding
25/01/18
CAN Change of Director's Interest Notices
25/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act
24/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act
23/01/18
CAN Notice given under section 708A(5)(e) of Corporations Act
22/01/18
CAN Appendix 3B
19/01/18
CAN Appendix 3B
19/01/18
CAN Share Purchase Plan closes heavily oversubscribed
19/01/18
CAN Change of Director's Interest Notice
17/01/18
CAN Results of Meeting
17/01/18
CAN Federal Government Announcement on Medicinal Cannabis Export
04/01/18PRICE SENSITIVE
CAN Ceasing to be a substantial holder
22/12/17
CAN Ceasing to be a substantial holder
21/12/17
CAN Change in substantial holding
21/12/17
CAN New Northern Cultivation and R&D Facility Commissioned
20/12/17
CAN Notice of General Meeting/Proxy Form
14/12/17
CAN Share Purchase Plan
13/12/17
CAN Notice given under section 708A(5)(e) of Corporations Act
12/12/17
CAN Appendix 3B
12/12/17
CAN Appendix 3B
11/12/17
CAN Cann Group Successfully Completes Placement
04/12/17PRICE SENSITIVE
CAN Investor Presentation
30/11/17
CAN Fully underwritten $60 million capital raise
30/11/17PRICE SENSITIVE
CAN Trading Halt
29/11/17PRICE SENSITIVE
CAN Results of Meeting
22/11/17
CAN Chairman's & CEO's Address to Shareholders
22/11/17
CAN Relocation of Corporate Headquarters to La Trobe University
02/11/17
CAN Change of Corporate and Registered Offices
02/11/17
CAN Cann Group Granted Cannabis Import / Export Licence
27/10/17PRICE SENSITIVE
CAN Licence Variations Granted
25/10/17PRICE SENSITIVE
CAN Notice of Annual General Meeting/Proxy Form
18/10/17
CAN Quarterly Activities Report and Appendix 4C
16/10/17PRICE SENSITIVE
CAN Cann Investor Presentation September 2017
01/09/17
CAN Cann Group Joins Medicinal Cannabis Information Portal
01/09/17PRICE SENSITIVE
CAN Appendix 4G
29/08/17
CAN Appendix 4E and 2017 Annual Report
29/08/17PRICE SENSITIVE
CAN Cann Group Completes First Harvest Production
28/08/17PRICE SENSITIVE
CAN Cann Group - CannaKorp Agreement Announcement
25/08/17PRICE SENSITIVE
CAN Price Query Response
18/08/17PRICE SENSITIVE
CAN Quarterly Activities Report and Quarterly Appendix 4C
28/07/17PRICE SENSITIVE
CAN Aurora and Cann Group Execute Technical Services Agreement
19/07/17PRICE SENSITIVE
CAN Investor Presentation
06/06/17
CAN Cann secures permits to start cultivation
30/05/17PRICE SENSITIVE
CAN Becoming a substantial holder
09/05/17
CAN Becoming a substantial holder
05/05/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
4.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.80M
Open High Low Value Volume
4.8¢ 4.8¢ 4.6¢ $11.93K 252.9K

Buyers (Bids)

No. Vol. Price($)
2 4849 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 198859 5
View Market Depth
Last trade - 15.32pm 22/11/2024 (20 minute delay) ?
Last
4.6¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
4.6¢ 4.7¢ 4.6¢ 129173
Last updated 15.52pm 22/11/2024 ?
CAN (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.